lifestyle.marketresearchjournals.com

Author: HAGENS BERMAN SOBOL SHAPIRO LLP

F5, Inc. (FFIV) Cybersecurity Incident-Related Securities Class Action Pending As Adverse Financial Impact Clarified – Hagens Berman

January 8, 2026
StubHub (STUB) Slapped with Securities Lawsuit Over IPO Disclosures — Hagens Berman

January 8, 2026
PRMB Investor Alert: Hagens Berman Scrutinizing Alleged Undisclosed Technology Failures and Supply Chain Risks in Pending Primo Brands (PRMB) Lawsuit

January 8, 2026
54% STRIDE (LRN) CRASH: Hagens Berman Scrutinizing Stride (LRN) Over Alleged “Ghost Students” Fraud and Concealed Tech Failure

January 8, 2026
Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability– Hagens Berman

January 8, 2026
Fermi Inc. (FRMI) Slapped With Securities Class Action Over IPO And Subsequent Disclosures — Hagens Berman

January 7, 2026
FFIV INVESTOR ALERT: Hagens Berman Investigating Alleged Claims Against F5, Inc. (FFIV) in Pending Securities Class Action Suit Following Disclosures of Security Breach

January 6, 2026
KLAR INVESTOR ALERT: Hagens Berman Notifies Klarna Group plc (KLAR) Investors of Feb. 20 Deadline in IPO Securities Class Action

January 6, 2026
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman

January 6, 2026
Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability– Hagens Berman

January 6, 2026